Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Treatment on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
2018-002648-10Phase 2Active
- Sponsor
- Strasbourg University Hospital
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of testosterone in multiple sclerosis (MS), sponsored by Strasbourg University Hospital. Primary endpoint: Primary neuroprotection/remyelination endpoint. Started Apr 2019; status: active.
02
Drugs
testosterone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2018-002648-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002648-10.